DK0576439T3 - Monoklonalt antistof mod LPS-kerne - Google Patents

Monoklonalt antistof mod LPS-kerne

Info

Publication number
DK0576439T3
DK0576439T3 DK92904901T DK92904901T DK0576439T3 DK 0576439 T3 DK0576439 T3 DK 0576439T3 DK 92904901 T DK92904901 T DK 92904901T DK 92904901 T DK92904901 T DK 92904901T DK 0576439 T3 DK0576439 T3 DK 0576439T3
Authority
DK
Denmark
Prior art keywords
thr
leu
tyr
arg
ser
Prior art date
Application number
DK92904901T
Other languages
Danish (da)
English (en)
Inventor
Hermann Gram
Padova Franco Di
George Robin Barclay
Ian Raymond Poxton
Original Assignee
Common Services Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Common Services Agency filed Critical Common Services Agency
Application granted granted Critical
Publication of DK0576439T3 publication Critical patent/DK0576439T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK92904901T 1991-03-13 1992-02-22 Monoklonalt antistof mod LPS-kerne DK0576439T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919105292A GB9105292D0 (en) 1991-03-13 1991-03-13 Improvements in or relating to organic compounds
PCT/EP1992/000380 WO1992016624A1 (fr) 1991-03-13 1992-02-22 Anticorps monoclonal dresse contre le noyau de lipopolysaccharide

Publications (1)

Publication Number Publication Date
DK0576439T3 true DK0576439T3 (da) 1999-11-01

Family

ID=10691487

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92904901T DK0576439T3 (da) 1991-03-13 1992-02-22 Monoklonalt antistof mod LPS-kerne

Country Status (10)

Country Link
EP (1) EP0576439B1 (fr)
JP (1) JP3328277B2 (fr)
AT (1) ATE179753T1 (fr)
AU (1) AU1261192A (fr)
CA (1) CA2105979C (fr)
DE (1) DE69229110T2 (fr)
DK (1) DK0576439T3 (fr)
ES (1) ES2131526T3 (fr)
GB (1) GB9105292D0 (fr)
WO (1) WO1992016624A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0776240B2 (ja) * 1983-05-06 1995-08-16 ベロス グル−プ エンドトキシンコア−と反応性のモノクロ−ナル抗体
CA2130436C (fr) * 1992-02-19 2001-04-10 John S. Abrams Clonage et expression des anticorps monoclonaux humanises diriges contre l'interleukine-4 humaine
US6749831B1 (en) 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
EP1521776A2 (fr) 2002-07-04 2005-04-13 Oncomab Gmbh Anticorps specifiques de neoplasme et utilisations associees
DE10311248A1 (de) 2003-03-14 2004-09-30 Müller-Hermelink, Hans Konrad, Prof. Dr. Humaner monoklonaler Antikörper
EP1531162A1 (fr) 2003-11-14 2005-05-18 Heinz Vollmers Anticorps SAM-6, spécifique d'adénocarcinome, et ses utilisations
DE10353175A1 (de) 2003-11-14 2005-06-16 Müller-Hermelink, Hans Konrad, Prof. Dr. Humaner monoklonaler Antikörper mit fettsenkender Wirkung
CA2760096C (fr) 2009-04-27 2018-10-30 Immuron Limited Preparation d'immunoglobuline enrichie anti-lps destinee au traitement ou a la prophylaxie de trouble pathogene
WO2012023051A2 (fr) 2010-08-17 2012-02-23 Immuron Ltd. Préparation d'immunoglobuline enrichie en anti-lps, destinée à être utilisée dans le traitement et/ou la prophylaxie d'un trouble pathologique
DE102011006781A1 (de) * 2011-04-05 2012-10-11 Mat-Malta Advanced Technologies Limited Antikörperprodukt, umfassend n spezifische Antikörper
DE102011006809A1 (de) 2011-04-05 2012-10-11 Freistaat Bayern vertreten durch die Julius-Maximilians-Universität Würzburg Verwendung eines Mittels aus Antikörpern und/oder Insulin-like growth factor-Antagonisten
WO2017083515A2 (fr) * 2015-11-10 2017-05-18 Visterra, Inc. Conjugués molécules anticorps-médicaments et leurs utilisations
JP7303110B2 (ja) 2017-01-18 2023-07-04 ビステラ， インコーポレイテッド 抗体分子－薬物コンジュゲートおよびその使用
KR20240085798A (ko) 2020-04-03 2024-06-17 비스테라, 인크. 항체 분자-약물 접합체 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0776240B2 (ja) * 1983-05-06 1995-08-16 ベロス グル−プ エンドトキシンコア−と反応性のモノクロ−ナル抗体
EP0183876A1 (fr) * 1984-11-27 1986-06-11 The Board Of Trustees Of The Leland Stanford Junior University Anticorps monoclonaux pour le noyau d'endotoxines et leur application
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
FR2606421B1 (fr) * 1986-11-12 1990-01-26 Roussel Uclaf Anticorps monoclonaux antigram (-) procede de preparation et applications
GB2218703B (en) * 1988-05-10 1992-10-28 Sumitomo Chemical Co Human monoclonal antibody to p.aeruginosa: its production and use
WO1990003186A1 (fr) * 1988-09-19 1990-04-05 Cetus Corporation Endotoxine bacterienne gram negative bloquant des anticorps monoclonaux

Also Published As

Publication number Publication date
CA2105979A1 (fr) 1992-09-14
WO1992016624A1 (fr) 1992-10-01
EP0576439A1 (fr) 1994-01-05
AU1261192A (en) 1992-10-21
ATE179753T1 (de) 1999-05-15
JPH06505867A (ja) 1994-07-07
DE69229110T2 (de) 1999-11-25
ES2131526T3 (es) 1999-08-01
DE69229110D1 (de) 1999-06-10
CA2105979C (fr) 2003-05-13
EP0576439B1 (fr) 1999-05-06
GB9105292D0 (en) 1991-04-24
JP3328277B2 (ja) 2002-09-24

Similar Documents

Publication Publication Date Title
DK0576439T3 (da) Monoklonalt antistof mod LPS-kerne
US6342587B1 (en) A33 antigen specific immunoglobulin products and uses thereof
JP6400480B2 (ja) ペプチドグリカン認識タンパク質１に結合する抗体
RU2017137010A (ru) Анти-сеасам6 антитела и их применения
KR102866306B1 (ko) 신경 성장 인자에 대한 단일 클론 항체, 및 이의 코딩 유전자 및 용도
MY145703A (en) Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumors
KR970707160A (ko) 인체 인터루킨 5 수용체 알파-사슬에 대한 항체 (antibody against alpha-chain of human interleukin 5 receptor)
US20200347130A1 (en) CD96 Antibody, Antigen-Binding Fragment and Pharmaceutical use Thereof
RU96115107A (ru) "очеловеченные" антитела и их использование
CY1113296T1 (el) Υβριδικο ανθρωπινο/τρωκτικου ιgg αντισωμα προς cd3 και μεθοδοι κατασκευης αυτου
US20250011455A1 (en) ANTI-CD39 Antibody, Preparation Method Therefor And Use Thereof
RU2003100512A (ru) Антитела к человеческому мср-1
JP2020521504A (ja) 抗ｃｄ４０抗体、その抗原結合フラグメント、およびその医学的使用
DE3485432D1 (de) Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene.
CN107522783A (zh) 一种抗白介素17a 的抗体、其制备方法和应用
CN110461874B (zh) 抗gitr抗体、其抗原结合片段及其医药用途
CN113661176B (zh) 用于预防和治疗单纯疱疹病毒感染的单克隆抗体
CA2525657A1 (fr) Anticorps monoclonal humain specifique de lipopolysaccharides (lps) du serotype iats o6 de pseudomonas aeruginosa
CN114957468A (zh) 一种抗Siglec15抗体及其用途
WO2024012434A1 (fr) Anticorps, fragment de liaison à l'antigène de celui-ci, et leur utilisation pharmaceutique
Muneta et al. Production of monoclonal antibodies to porcine interleukin-18 and their use for immunoaffinity purification of recombinant porcine interleukin-18
WO2019200255A1 (fr) Anticorps monoclonal humain spécifique de la capsule de mycobacterium tuberculosis à haute affinité
KR890016165A (ko) 수도모나스 아에루기노사(Pseudomonas aeruginosa)에 대한 모노클로날 항체, 이의 제조방법 및 용도
CN115335402B (zh) 特异性抗原结合分子,其制备方法及医药用途
RU2539752C2 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО И АНТИГЕНСВЯЗЫВАЮЩИЙ ФРАГМЕНТ (Fab), СВЯЗЫВАЮЩИЕСЯ С ИНТЕРФЕРОНОМ- γ ЧЕЛОВЕКА, ФРАГМЕНТЫ ДНК, КОДИРУЮЩИЕ УКАЗАННОЕ АНТИТЕЛО И АНТИГЕНСВЯЗЫВАЮЩИЙ ФРАГМЕНТ, КЛЕТКА, ТРАНСФОРМИРОВАННАЯ ФРАГМЕНТОМ ДНК, И СПОСОБ ПОЛУЧЕНИЯ УКАЗАННОГО АНТИТЕЛА И АНТИГЕНСВЯЗЫВАЮЩЕГО ФРАГМЕНТА